L

LifeMD Inc
NASDAQ:LFMD

Watchlist Manager
LifeMD Inc
NASDAQ:LFMD
Watchlist
Price: 3.49 USD 2.35% Market Closed
Market Cap: 168m USD

LifeMD Inc
Investor Relations

LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 232 full-time employees. The company went IPO on 2001-07-11. The firm's portfolio of brands is included within two operating segments: Telehealth and WorkSimpli. Its telehealth platform provides patients with access to licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis. In addition to its telehealth offerings, the Company sells complementary nutritional supplements and over-the-counter (OTC) products. Its products are available on a subscription basis, where patients can subscribe to receive regular shipments of prescribed medications or products. Its Shapiro MD brand offers products for male and female hair loss, OTC minoxidil, medical device, and a personalized telehealth platform. Rex MD is its men's brand, which offers access to provider-based treatment for erectile dysfunction, as well as treatment for other common men's health issues.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 17, 2025
AI Summary
Q3 2025

Revenue Growth: LifeMD reported Q3 consolidated revenue of $60.2 million, up 13% year-over-year, with Telehealth revenue specifically up 18%.

Profitability: Adjusted EBITDA increased 30% year-over-year for Telehealth, reaching $2.9 million. Company-wide adjusted EBITDA was $5.1 million, up from $4.3 million.

Guidance: Management expects full-year 2025 revenue of $192–193 million and adjusted EBITDA of $13.5–14.5 million, representing 24% and 254% growth over 2024, respectively.

Strategic Progress: The company advanced women's and behavioral health verticals, secured compounding pharmacy approval, and divested non-core assets to focus on virtual care and pharmacy.

Weight Management: Branded GLP-1 drug access and pricing are improving, with new lower-cost offers for Wegovy, Ozempic, and anticipated oral therapies expected to drive growth in 2026.

Insurance Enablement: Broad insurance coverage was launched, resulting in a 33% reduction in customer acquisition costs and positioning LifeMD to benefit from anticipated Medicare/Medicaid GLP-1 coverage.

Margins: Gross margin declined due to product mix shift toward branded drugs; further mild erosion is expected as business mix evolves.

Balance Sheet: The company has no debt and $23.8 million in cash, its strongest liquidity position ever.

Key Financials
Revenue
$60.2 million
Telehealth Revenue
$47.3 million
Adjusted EBITDA
$5.1 million
Telehealth Adjusted EBITDA
$2.9 million
Active Subscribers
over 310,000
Gross Margin
88%
Telehealth Gross Margin
86%
Gross Profit
$52.8 million
Net Loss Attributable to Common Stockholders
$4.6 million
Earnings Per Share (Loss)
$0.10 loss per share
Cash
$23.8 million
Debt
$0
Q4 Revenue Guidance
$45–46 million
Q4 Adjusted EBITDA Guidance
$3–4 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Justin Schreiber
Chairman & CEO
No Bio Available
Mr. Marc Benathen
Chief Financial Officer
No Bio Available
Mr. Stefan Galluppi
Chief Innovation Officer
No Bio Available
Ms. Maria E. Stan CPA
Controller & Principal Accounting Officer
No Bio Available
Mr. Dennis Wijnker
Chief Technology Officer
No Bio Available
Mr. Eric H. Yecies
Chief Legal Officer, General Counsel & Secretary
No Bio Available
Mr. Shane Biffar
Chief Compliance Officer & Deputy General Counsel
No Bio Available
Ms. Jessica Friedeman
Chief Marketing Officer
No Bio Available
Mr. Nicholas P. Alvarez
Chief Acquisition Officer & Head of Customer Acquisition
No Bio Available
Mr. Varun Pathak
Chief Software Engineer & Co-Founder of PDF Simpli
No Bio Available

Contacts

Address
NEW YORK
New York City
236 Fifth Avenue, Suite 400
Contacts
+18663515907.0
lifemd.com